Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-20011055696.40.33614074444.21011295.8
China - Qidong 1992-200066993.60.32160182.765197.3
China - Shangai 1992-1995518486.30.000000.05184100.0
China - Tianjin 1991-1999587686.10.0238130.2586399.8
Costa Rica 1995-2000285492.42.572316439213.7246286.3
Cuba 1994-1995292969.425.67492976025.9216974.1
Gambia 1993-19979339.81.1111203234.46165.6
India - Barshi 1993-200012491.10.000000.0124100.0
India - Bhopal 1991-199534887.90.628418725.026175.0
India - Chennai 1990-1999359585.42.072456052814.7306785.3
India - Karunagappally 1991-199719393.81.021031.619098.4
India - Mumbai 1992-1994775183.55.240434194575.9729494.1
Philippines - Manila 1994-199551087.80.009329518.641581.4
Philippines - Rizal 1996-1997157090.35.993174427117.3129982.7
Saudi Arabia - Riyadh 1994-199632199.70.00185237.229892.8
Singapore 1993-1997339598.90.27147371915.6320494.4
Republic of Korea - Busan 1996-2001272093.52.362160782.9264297.1
Republic of Korea - Incheon 1997-2001150590.83.95910604.0144596.0
Republic of Korea - Seoul 1993-1997590788.33.319635605529.3535590.7
Thailand - Chiang Mai 1993-199762193.61.496537712.454487.6
Thailand - Khon Kaen 1993-199744683.61.15221286.341893.7
Thailand - Lampang 1990-200084289.91.41200121.483098.6
Thailand - Songkhla 1990-199966591.61.2895010315.556284.5
Turkey - Izmir 1995-1997134695.60.00611171.3132998.7
Uganda - Kampala 1993-199723363.90.006657130.516269.5
Zimbabwe - Harare 1993-199728777.77.722522910.125889.9



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period